Fresh Tracks Therapeutics Inc (OTCPK:FRTX)
$ 0.74 -0.005 (-0.67%) Market Cap: 4.45 Mil Enterprise Value: -4.51 Mil PE Ratio: 0 PB Ratio: 0.45 GF Score: 52/100

Q2 2022 Brickell Biotech Inc Earnings Call Transcript

Aug 11, 2022 / 08:30PM GMT
Release Date Price: $3.27 (-10.66%)
Operator

Welcome, everyone, to the Brickell Biotech Second Quarter 2022 Financial Results Conference Call. (Operator Instructions)

As a reminder, this conference call is being recorded. I would now like to turn the call over to Garth Russell from LifeSci Advisors, Garth?

Garth Russell
LifeSci Advisors, LLC - MD of Corporate Communications

Thank you, operator, and good afternoon, everyone. Joining me on today's call are Brickell's Chief Executive Officer, Rob Brown; President and Chief Operating Officer, Andy Sklawer; Chief Financial Officer, Bert Marchio; Chief Medical Officer, Dr. Monica Luchi; and Chief R&D Officer, Deepak Chadha.

Before we begin, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are subject to risks and uncertainties that could cause actual results to differ. Please note that these forward-looking statements reflect our opinions only as of the date of this call. We will not undertake obligation to revise or publicly release the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot